6th annual hematology and medical oncology board review€¦ · 6th annual hematology and medical...

4
6 th Annual Hematology and Medical Oncology Board Review: CONTEMPORARY PRACTICE MARCH 9-12, 2018 Zuckerman Research Center 417 East 68th Street | New York, NY 10065

Upload: nguyenthuy

Post on 03-Apr-2018

231 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: 6th Annual Hematology and Medical Oncology Board Review€¦ · 6th Annual Hematology and Medical Oncology Board Review: CONTEMPORARY PRACTICE MARCH 9-12, 2018 Zuckerman Research

6th AnnualHematology and Medical Oncology Board Review: CONTEMPORARY PRACTICE

MARCH 9-12, 2018Zuckerman Research Center417 East 68th Street | New York, NY 10065

Page 2: 6th Annual Hematology and Medical Oncology Board Review€¦ · 6th Annual Hematology and Medical Oncology Board Review: CONTEMPORARY PRACTICE MARCH 9-12, 2018 Zuckerman Research

This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

Educational Objectives

• State-of-the-science in diagnosis, staging, andtherapeutic management of solid tumor cancers

• State-of-the-science in diagnosis, staging, andtherapeutic management of hematologic cancers

• Recent treatment advances in solid tumor andhematologic oncology and their impact on modernclinical practice

Target Audience

The target audience for this course includes medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents

.MSK Course Directors

MSK FACULTY

David H. Ilson, MD, PhDAttending Physician, Gastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

Craig H. Moskowitz, MDSteven A. Greenberg Chair in Lymphoma Research Clinical Director, Division of Hematologic OncologyAttending Physician, Lymphoma and Adult BMT ServicesDepartment of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

Ghassan K. Abou-Alfa, MD Associate Attending Gastrointestinal Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

Carol Aghajanian, MDAttending Physician, Chief Gynecologic Medical Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

Dean F. Bajorin, MDAttending Physician Genitourinary Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

Renier J. Brentjens, MD, PhDDirector, Cellular Therapeutics Center Associate AttendingLeukemia ServiceDivision of Hematologic OncologyDepartment of Medicine

Andrea Cercek, MDAssistant Attending Physician Gastrointestinal Oncology Service Division of Solid Tumor OncologyDepartment of Medicine

Paul B. Chapman, MDMember and Attending PhysicianMelanoma Clinical DirectorMelanoma and Immunotherapeutics Service Department of Medicine

Hiram S. Cody III, MDAttending Surgeon Breast ServiceDepartment of Surgery Professor of Surgery, Weill Cornell Medical College

Chau T. Dang, MD Chief, Westchester Medical Oncology ServiceBreast Medicine ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Maura N. Dickler, MD Section Head, Endocrine Therapy Clinical Research ProgramBreast Medicine ServiceAssociate Member, Department of MedicineAssociate Professor of Medicine, Weill Cornell Medical College

Mark A. Dickson, MD Assistant Attending Physician Sarcoma Medical Oncology Service Division of Solid Tumor Oncology Department of Medicine

Darren R. Feldman, MDAssistant Attending Genitourinary Oncology Service Bone Marrow Transplant ServiceAssistant Professor of Medicine, Weill Cornell Medical College

Mrinal M. Gounder, MD Assistant Attending PhysicianSarcoma Medical Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Rachel N. Grisham, MD Assistant Attending PhysicianGynecologic Medical Oncology ServiceDepartment of Medicine

Christian Grommes, MDAssistant Attending PhysicianNeurology ServiceDepartment of Neurology

Komal Jhaveri, MD, FACPAttendingBreast Medicine Service and Early Drug Development ServiceDepartment of Medicine

Philip Kantoff, MDChairman, Department of MedicineProfessor of Medicine, Weill Cornell Medical College

Anita Kumar, MDClinical Director of Lymphoma Outpatient ServicesAssistant AttendingLymphoma ServiceDepartment of Medicine

C. Ola Landgren, MD, PhDChief, Myeloma ServiceDivision of Hematologic OncologyDepartment of Medicine

Bob T. Li, MD, MPH Assistant Attending PhysicianThoracic Oncology Service, Developmental TherapeuticsDivision of Solid Tumor OncologyDepartment of Medicine

Simon Mantha, MD, MPHAssociate Attending Physician Hematology ServiceDivision of Hematologic OncologyDepartment of Medicine

Michael J. Mauro, MDLeader, Myeloproliferative Neoplasms Program Attending PhysicianLeukemia ServiceDivision of Hematologic OncologyDepartment of Medicine

Beryl McCormick, MD, FACRChief, External Beam Radiotherapy ServiceAttending Radiation Oncologist Department of Radiation Oncology

Jodi Mones, MDAssociate AttendingHematology ServiceDepartment of Medicine

Eileen M. O’Reilly, MDAttendingAssociate Director for Clinical Research,David M. Rubenstein Center for Pancreatic CancerGastrointestinal Oncology ServiceDivision of Solid Tumor Oncology Department of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

Paul K. Paik, MDAssistant AttendingClinical Director, Thoracic Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Miguel-Angel Perales, MDDeputy Chief, Adult Bone Marrow Transplantation ServiceDirector, Adult Stem Cell Transplantation FellowshipBone Marrow Transplant ServiceDepartment of MedicineProfessor of Medicine, Weill Cornell Medical College

David G Pfister, MD, FACP, FASCOService Chief, Head and Neck OncologyCo-Leader, Head and Neck Cancer Center Disease Management TeamAssociate Deputy Physician-in-Chief, Strategic PartnershipsAttending Physician and MemberDivision of Solid Tumor OncologyDepartment of MedicineProfessor, Department of Medicine, Weill Cornell Medical College

Leonard B. Saltz, MDAttending Physician and MemberGastrointestinal Oncology ServiceProfessor of Medicine, Weill Cornell Medical College

Susan K. Seo, MDAssociate Attending Infectious Disease ServiceDivision of General Medicine Department of Medicine

Gerald A. Soff, MDChief, Hematology ServiceDivision of Hematologic OncologyDepartment of Medicine

Zsofia K. Stadler, MDAssociate Attending PhysicianClinical Director, Clinical Genetics ServiceGastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Martin S. Tallman, MDChief, Leukemia ServiceDivision of Hematologic OncologyDepartment of Medicine

Anna M. Varghese, MDAssistant Attending PhysicianGastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Martin H. Voss, MDAssistant Attending PhysicianGenitourinary Oncology ServiceDepartment of Medicine

Marjorie G. Zauderer, MD, MS, FACPCo-Director MSK Mesothelioma ProgramAssistant Attending PhysicianThoracic Oncology ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Andrew D. Zelenetz, MD, PhDMedical Director, Quality InformaticsAttending PhysicianLymphoma ServiceDivision of Hematologic OncologyDepartment of Medicine

6th Annual Hematology and Medical Oncology Board Review:CONTEMPORARY PRACTICE

Page 3: 6th Annual Hematology and Medical Oncology Board Review€¦ · 6th Annual Hematology and Medical Oncology Board Review: CONTEMPORARY PRACTICE MARCH 9-12, 2018 Zuckerman Research

7:30 am Breakfast & Registration

8:00 am DEPARTMENT OF MEDICINE GRAND ROUNDS

CART cellsRenier J. Brentjens, MD, PhD

9:00 am Colon CancerLeonard B. Saltz, MD

10:00 am MelanomaPaul B. Chapman, MD

10:45 am Prostate CancerPhilip Kantoff, MD

11:30 am Kidney CancerMartin H. Voss, MD

12:15 pm Lunch Break

1:00 pm MesotheliomaMarjorie G. Zauderer, MD, MS, FACP

1:15 pm Urothelial CancerDean F. Bajorin, MD

2:00 pm Ovarian CancerRachel N. Grisham, MD

2:45 pm Uterine/Cervix/ Other GYN CancersCarol Aghajanian, MD

3:30 pm Coffee Break

3:45 pm Testis Cancer Darren R. Feldman, MD

4:30 pm Breast Cancer/SurgeryHiram S. Cody III, MD

5:00 pm Breast Cancer/Radiation TherapyBeryl McCormick, MD, FACR

5:30 pm Esophageal & Gastric CancerDavid H. Ilson, MD, PhD

6:00 pm Adjourn

March 9, 2018

6:30 am Breakfast

7:00 am Small Cell Lung CancerBob T. Li, MD, MPH

7:30 am Breast Cancer/Advanced DiseaseKomal Jhaveri, MD, FACP

8:30 am Breast Cancer/Adjuvant TherapyChau T. Dang, MD

9:30 am Breast Cancer/Hormonal Therapy Maura N. Dickler, MD

10:00 am Carcinoma of Unknown PrimaryAnna M. Varghese, MD

10:30 am Coffee Break

10:45 am Hepatobiliary CancersGhassan K. Abou-Alfa, MD

11:30 am Pancreatic & Neuroendocrine CancerEileen M. O’Reilly, MD

March 10, 2018

12:15 pm Lunch Break

1:15 pm Non Small Cell Lung CancerPaul K. Paik, MD

2:00 pm Head and Neck, Thyroid CancerDavid G. Pfister, MD

2:45 pm Anal/Rectal CancerAndrea Cercek, MD

3:15 pm Coffee Break

3:30 pm GeneticsZsofia K. Stadler, MD

4:00 pm CNS TumorsChristian Grommes, MD

4:30 pm SarcomaMark A. Dickson, MD

5:00 pm Infectious DiseaseSusan K. Seo, MD

5:30 pm Adjourn

6:30 am Breakfast

7:00 am Pharmacology I & IIMrinal M. Gounder, MD

9:20 am Coffee Break

9:30 am Low Grade NHL/CLLAndrew D. Zelenetz, MD, PhD

10:30 am DLBCL/MCL/BLAnita Kumar, MD

11:30 am HL/T CellCraig H. Moskowitz, MD

12:30 pm Lunch Break

1:15 pm Auto/AlloMiguel-Angel Perales, MD

2:15 pm AML/ALLMartin S. Tallman, MD

3:15 pm Coffee Break

3:30 pm MDS/MPNMichael J. Mauro, MD

4:30 pm Myeloma/AmyloidC. Ola Landgren, MD, PhD

5:30 pm Adjourn

March 11, 2018

7:30 am Breakfast

8:00 am The Role of the New Direct Oral Anticoagulants in PracticeSimon Mantha, MD, MPH

9:00 am Thrombocytopenia, ITP and BeyondGerald A. Soff, MD

10:00 am Approach to The Bleeding PatientGerald A. Soff, MD

11:00 am Sickle Cell Disease, ThalassemiaJodi Mones, MD

12:00 pm Adjourn

March 12, 2018Benign Hematology

Scientific Agenda

Page 4: 6th Annual Hematology and Medical Oncology Board Review€¦ · 6th Annual Hematology and Medical Oncology Board Review: CONTEMPORARY PRACTICE MARCH 9-12, 2018 Zuckerman Research

Registration

Physicians (MDs, PhDs and DOs) $1,400

Fellows, Residents, RNs & Other Healthcare Professionals $875

Industry Professionals* $2,450

Registration Fees

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Register Online:www.mskcc.org/HemOncBoardReview

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary needs.

30% Discounted Rate for MSK Alumni and MSK Alliance Members: MSK offers a 30% discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for a promotion code or more information.

MSK Staff Registration: Registration is complimentary for MSK staff. However, you must register online: www.mskcc.org/HemOncBoardReview

ACCREDITATION STATEMENT

MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT

MSK designates this live activity for a maximum of 31.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC RECOGNITION STATEMENT

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 31.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

FACULTY DISCLOSURE

It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it provides as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity provided by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

LOCATION

Memorial Sloan Kettering Cancer Center Mortimer B. Zuckerman Research Center417 East 68th Street New York, NY 10065

ACCOMMODATIONS

MSK has negotiated special rates and amenities at select hotels in Manhattan. For information on hotels in the area of MSK with discounted rates, please visit: www.mskcc.org/cme.

CONTACT

For more information, including all upcoming MSK CME courses, visit our website at www.mskcc.org/cme. To contact us directly, email [email protected].

Join the conversation:

#MSKHemOncCME

/MSKCME

@MSKCME

MSK CME LinkedIn Group